Showing results (11-20 of 178) with videos related to
Sort By:
Pageof 18
Transplantation|November 10, 1998
Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptideN C Chowdhury, D V Saborio, M Garrovillo, et al.Current Opinion in Nephrology and Hypertension|May 1, 1996
Immunomodulatory function of major histocompatibility complex-derived peptidesB Murphy, M H SayeghClinical and Experimental Rheumatology|November 21, 2007
The evolution of the immunobiology of co-stimulatory pathways: clinical implicationsS Trikudanathan, M H SayeghExpert Opinion on Investigational Drugs|November 4, 2000
CTLA4-Ig: a novel immunosuppressive agentN Najafian, M H SayeghAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1996
Endothelin in organ transplantationB Watschinger, M H SayeghThe American Journal of Pathology|March 10, 2001
CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosisK S Kim, M D Denton, A Chandraker, et al.Postgraduate Medical Journal|July 1, 1997
Maintenance pharmacological immunosuppressive strategies in renal transplantationJ P Vella, M H SayeghInternational Reviews of Immunology|January 1, 1996
Role of indirect allorecognition in allograft rejectionM H Sayegh, C B CarpenterKidney International. Supplement|January 1, 1996
Novel immunotherapeutic strategies using MHC derived peptidesM H Sayegh, A M KrenskyAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 20, 1998
Interactions between cyclosporine and newer antidepressant medicationsJ P Vella, M H SayeghPageof 18